AzTrials
AzTrials

Missing TeethNCT07080177

Assessment of Hard and Soft Tissue Changes Following XCM Versus FGG Simultaneous With Delayed Dental Implant Placement

A study testing Free gingival graft simultaneous with delayed implant placement and Xenogeneic collagen matrix simultaneous with delayed implant placement in people with Missing Teeth, run by Cairo University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Teeth loss are usually associated with alterations of extraction sockets result in obviously absorbed alveolar ridges and are often accompanied with soft tissue atrophy such as narrow keratinized tissue and a shallow vestibule. Lack of peri-implant keratinized tissue is a potential risk to peri-implant diseases. Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Missing Teeth
What is being tested?
Free gingival graft simultaneous with delayed implant placement and Xenogeneic collagen matrix simultaneous with delayed implant placement
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteEgypt
Study dates
22 Sep 2025to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Adults above the age of 18 years.
  • Presence of 2mm or less of keratinized tissue width
  • Sufficient alveolar ridge width minimum of 6 mm
  • Patients with good oral hygiene as evidenced by plaque index (PI)<1 and showing cooperation or compliance with treatment.

Who cannot join

  • Patients diagnosed with periodontal diseases (Caton et al., 2018).
  • Acute active infection at implant sites
  • Patients with medical conditions that would compromise the surgical procedures; uncontrolled diabetes mellitus, taking intravenous bisphosphonates for treatment of osteoporosis and radiotherapy
  • Patients with parafunctional habits.
  • Smokers (≥10 cigarettes per day),

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Parryhan M Abdelsamie, PhD contact

01003082353

Parryhan.abdelsamie@dentistry.cu.edu.eg

Maged M Seleet, PhD contact

01000367625

Egypt1 site
  • MTI University

    Cairo

Other trials in Egypt

About this study

Official title: Assessment of Hard and Soft Tissue Changes Following Xenogeneic Collagen Membrane Versus Free Gingival Graft Simultaneous With Delayed Dental Implant Placement: Randomized Controlled Clinical Trial

Teeth loss are usually associated with alterations of extraction sockets result in obviously absorbed alveolar ridges and are often accompanied with soft tissue atrophy such as narrow keratinized tissue and a shallow vestibule.

Lack of peri-implant keratinized tissue is a potential risk to peri-implant diseases. Although the role of width of KM in maintaining peri-implant health is a controversial topic, the majority of high-level evidence has suggested that a minimum KM width (KMW) of 2 mm around the dental implants is critical to maintain peri-implant health and the long-term survival of dental implants.

Read the detailed description

This study will be carried out on patients attending outpatient clinic of Oral maxillofacial surgery and Periodontology Departments, Faculty of Dentistry. Modern University for Technology and Information, Cairo, Egypt.

P: Healthy patients with posterior missing teeth with deficient keratinized tissue to receive delayed dental implant placement I: Xenogeneic collagen membrane (XCM) simultaneous with delayed implant placement C: Free gingival graft (FGG) simultaneous with delayed implant placement O: Keratinized tissue width (KMW), graft shrinkage (GS), marginal bone loss (MBL) T- One year S- Randomized controlled clinical trial.

Eligible patients will be divided into equal proportions between control group and test group.

The control group "Group 1" will receive FGG simultaneous with implant placement The test group "Group 2" will receive XCM simultaneous with implant placement

Conditions
Missing Teeth
Being tested
Free gingival graft simultaneous with delayed implant placement, Xenogeneic collagen matrix simultaneous with delayed implant placement
Keywords
xenogeneic collagen membrane, free gingival graft, xenogeneic collagen matrices, simultaneous implant placement
Medical subject headings
Anodontia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Free gingival graft simultaneous with delayed implant placementProcedure or surgery

    XCM grafts (of bovine origin)

  • Xenogeneic collagen matrix simultaneous with delayed implant placementProcedure or surgery

    A FGG will be harvested from the palate between first premolar and first molar

Study groups in NCT07080177
Study groupRoleWhat they receive
Xenogeneic collagen matrix simultaneous with delayed implant placementExperimentalTissue punch technique implants will be placed. XCM grafts (of bovine origin) will be trimmed to the required dimensions and will be fixed to the periosteum and sutured to the buccal peri-implant mucosa
Receives: Procedure: Xenogeneic collagen matrix simultaneous with delayed implant placement
Free gingival graft simultaneous with delayed implant placementActive comparatorTissue punch technique implants will be placed. A FGG will be harvested from the palate then the outlined graft will be placed and sutured to the recipient bed of the buccal peri-implant mucosa
Receives: Procedure: Free gingival graft simultaneous with delayed implant placement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Keratinized tissue width

    mm

    Measured: One year

  2. graft shrinkage

    precentage

    Measured: One year

  3. marginal bone loss

    mm

    Measured: One year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2025
  2. Study start22 Sep 2025 (estimated)
  3. Primary completionAug 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07080177
Sponsor's protocol ID
MTI
Status last verified
Sep 2025
First submitted
15 Jul 2025
Last updated
12 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Free gingival graft simultaneous with delayed implant placement and Xenogeneic collagen matrix simultaneous with delayed implant placement in people with Missing Teeth, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 12 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Parryhan M Abdelsamie, PhD (01003082353, Parryhan.abdelsamie@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Keratinized tissue width (time frame: One year). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in